Parkinson's comes on slowly, and diagnosing the often-devastating movement disorder, particularly in its early stages, ...

US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects ...

There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...

Foremost experts in Movement Disorders, which include the fastest-growing brain disease, will convene to share about and guide the direction of global medical advancements, including artificial ...

A UNIGE team has discovered the genetic programs that allow motor neurons to retract from the spinal cord. This discovery ...

Patients with Parkinson’s disease (PD) suffer from a variety of movement disorders caused by a breakdown of brain neurons.

With an FDA action date of Sept. 26, Bristol Myers Squibb’s KarXT could soon be the first new type of schizophrenia drug in ...

The Ronnie Gardiner Method, a form of music-based movement therapy, shows promise in aiding rehabilitation for stroke ...

Johns Hopkins launches OneNeuro, a cross-disciplinary initiative to utilize emerging technologies and AI to finally crack the code on the enigmatic human brain ...

Scientists have identified the melatonin MT1 receptor as a key regulator of REM sleep, crucial for memory, dreaming, and ...

A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated neuropsychiatric conditions: Scientists have pinpointed the melatonin ...

Using piezoelectricity, a University of Houston engineering team has developed wearable sensors to examine eye movement to ...